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The cytosolic pattern recognition receptor NOD2 is activated by the peptido-
glycan fragment muramyl dipeptide to generate a proinflammatory immune
response. Downstream effects include the secretion of cytokines such as inter-
leukin 8, the upregulation of pro-interleukin 1b, the induction of autophagy,
the production of antimicrobial peptides and defensins, and contributions
to the maintenance of the composition of the intestinal microbiota. Polymorph-
isms in NOD2 are the cause of the inflammatory disorder Blau syndrome
and act as susceptibility factors for the inflammatory bowel condition Crohn’s
disease. The complexity of NOD2 signalling is highlighted by the observation
that over 30 cellular proteins interact with NOD2 directly and influence or regu-
late its functional activity. Previously, the majority of reviews on NOD2
function have focused upon the role of NOD2 in inflammatory disease or in its
interaction with and response to microbes. However, the functionality of NOD2
is underpinned by its biochemical interactions. Consequently, in this review,
we have taken the opportunity to address the more ‘basic’ elements of NOD2
signalling. In particular, we have focused upon the core interactions of NOD2
with protein factors that influence and modulate the signal transduction path-
ways involved in NOD2 signalling. Further, where information exists, such as
in relation to the role of RIP2, we have drawn comparisonwith the closely related,
but functionally discrete, pattern recognition receptor NOD1. Overall, we pro-
vide a comprehensive resource targeted at understanding the complexities of
NOD2 signalling.2. Introduction
Nucleotide-binding and oligomerization-domain containing 2 (NOD2) was the
second member of the nucleotide-binding domain and leucine-rich repeat
containing receptor (NLR) family to be identified [1], following the discovery of
NOD1 in 1999 [2]. These two receptors have similar domain architectures—a
C-terminal leucine-rich repeat (LRR) domain, a central NAIP, CIITA, HET-E and
TP1-containing (NACHT) domain and an N-terminal effector domain. The effec-
tor region consists of one caspase recruitment domain (CARD) in NOD1 and two
tandem CARDs in NOD2 (figure 1). Based on the recent structure of NLRC4 [3]
(PDB ID: 4KXF), it can be predicted that the NACHT domains in NOD1
and NOD2 are followed by a proximal helical domain (HD1), a winged-helix
domain (WH) and a distal helical domain (HD2).
These structural similarities accompany similarity in function—NOD1 and
NOD2 are believed to be held in an autoinhibited state by their LRRs, are
activated by peptidoglycan fragments, bind nucleotides and oligomerize
through their NACHT domains and engage the downstream signalling molecule
receptor-interacting protein 2 (RIP2) through their effector domains [4].
Despite these similarities, research on NOD2 has been more prominent, pre-
dominantly owing to the identification of numerous NOD2 single nucleotide
polymorphisms (SNPs) which are associated with Crohn’s disease or causal
for Blau syndrome. The role of NOD2 in these diseases has been illuminated
953
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Figure 1. The domain architecture of NOD1, NOD2 and RIP2. Exons are shown in alternating blue and green blocks. Protein domains as listed in the NCBI RefSeq
database are shown in boxes (Accession numbers: NOD1—NP_006083; NOD2—NP_07115; RIP2—NP_003812). The length of each protein is shown. CARD,
caspase recruitment domain; NACHT, NAIP, CIITA, HET-E and TP1-containing; LRR, leucine-rich repeats.
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2by the identification of proteins, such as ATG16L1 and
CARD9, which are both linked to Crohn’s disease [5,6] and
interact with NOD2 [7–9]. As well as these binding partners
NOD2 has been reported to bind a wide variety of other
proteins (table 1 and figure 2). The identification of similari-
ties between subgroups of these proteins may provide
insights into the physiological roles of NOD2 and its contribu-
tions to disease. In this review, we provide a comprehensive
reference table of currently reported NOD2 binding part-
ners and discuss the role and contribution of these to NOD2
signalling (table 1).3. The stability, autoinhibition and
degradation of NOD2
NOD2 is maintained in an inactive, autoinhibited confor-
mation in the cell through interactions between the NACHT
and LRR domains and interaction with cellular chaperones.
Hahn [29] originally proposed that NOD1 interacts with the
chaperone protein heat shock protein 90 (HSP90), which pro-
vides stability in a manner analogous to some plant R
proteins. This hypothesis was extended to NOD2 by da Silva
Correia et al. [44], who used HSP90 siRNA and a small
molecule HSP90 inhibitor, geldanamycin, to show the impor-
tance of this chaperone for NOD1 and NOD2 stability in
MCF-7 cells. This study also went on to investigate the role of
SGT1, another regulator of R protein activity. While SGT1
bound NOD1 and NOD2, it was only important for cytokine
signalling through NOD1 and its knockdown by siRNA did
not affect the stability of either protein. Not long after, a
study by Mayor et al. [30] implicated SGT1 and HSP90 as
important for NOD2 signalling, though experimentation was
restricted to the inhibitory effects of geldanamycin onmuramyl
dipeptide (MDP) signalling.
The association betweenHSP90 andNOD2was reproduced
by Lee et al. [31], who confirmed its importance for NOD2 stab-
ility. In this case,HSP90was suggested to act aspart of anegative
feedback loop, wherein activation of NOD2 causes its dis-
sociation from HSP90 and subsequent, proteasome-dependent
degradation. The role of HSP90 was again confirmed using
small molecule inhibitors, while the proteasome inhibitor
MG-132 blockedNOD2degradation [31]. Aswell as dissociation
from HSP90, the negative feedback loop was shown to involve
SOCS3, a NOD2-binding, MDP-inducible protein which was
at least partially responsible for the ubiquitination of NOD2
leading to proteasomal degradation [31]. SOCS3 and HSP90both bound to the CARDs of NOD2 and so may be mutually
exclusive complexes, and it was hypothesized that SOCS3
could link NOD2 to an as yet unknown E3 ligase. A candidate
E3 ligase for this process is TRIM27, which has been reported
to be important for the ubiquitination and degradation of
NOD2 [49].
More recently, HSP70 has also been shown to interact
with, and stabilize, NOD2 [28]. In this work, overexpression
of HSP70 resulted in an increase in NF-kB activity following
ligand-mediated stimulation of NOD2. In contrast, reducing
HSP70 levels through the use of the small molecule inhibitor
KNK347 led to associated reduction inNF-kB signalling.Analy-
sis of NOD2 protein levels demonstrated that HSP70was acting
to stabilize the NOD2 protein, as when HSP70 levels were
reduced the half-life of NOD2 decreased [28]. It remains to be
seen whether all these chaperones are acting in concert with
one another or whether they can promote NOD2 stability
independently.4. Recognition of ligand by NOD2
NOD2 is the bona fide cytoplasmic receptor for the peptidogly-
can fragment MDP [50]. The introduction of MDP into the
cytoplasm can be achieved by multiple pathways including:
peptide transporters SLC15A1, 3 and 4 [45,51–53]; invasive
bacteria, such as Shigella flexneri, shedding peptidoglycan
[54]; and the absorption of outer membrane vesicles released
from Gram-negative bacteria [55,56].
Using both biophysical and biochemical approaches, it
has been shown recently that MDP interacts directly with
NOD2 [57,58]. It is generally believed that recognition is
mediated by the NOD2 LRRs [4,57,59,60] although a critical
role for the NACHT region has been suggested [58], though
this may represent a requirement for correct LRR folding in
the cell.
NOD2 can also undergo autoactivation, and this is
observed in the rare, autosomal dominant, inflammatory
disorder Blau syndrome which is caused by NOD2 poly-
morphisms [61]. NOD2 SNPs that cause Blau syndrome
cluster into two regions of NOD2—the nucleotide/Mg2þ
binding pocket, and helical domain 1 between the NACHT
and LRR. This has led to the suggestion that the mechanism
by which autoactivation occurs is likely to result from either
interference with nucleotide binding and hydrolysis, or inter-
ference with chaperone binding and the intramolecular
contacts between the NOD2 NACHT and helical domain 1
with the LRR [62].
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Figure 2. NOD2-interaction partners influence a wide range of NOD2 functions. A schematic of the reported interactions between NOD2 and other cellular proteins.
For the sake of simplicity, only a selection of proteins are displayed in direct contact with NOD2. Key NOD2 functional outputs are shown in black boxes. Protein
partners influencing these functions directly are listed in the relevant location. Protein impacts on NOD2 are highlighted with coloured arrows. Proteins which exert
their influence and interact with NOD2 at a predominantly membrane location are labelled in gold. Where the precise role of a protein partner is uncertain this is
represented by a question mark, and the protein has been located in the most likely region of influence.
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55. NOD2 and the adaptor protein RIP2
RIP2 is the best-studied interaction partner of NOD2 and is
important for the activation of the NF-kB [42,63] and MAPK
pathways [64,65] by NOD2 and also NOD1 [42]. Although
the importance of RIP2 in NOD signalling has been well
demonstrated, many questions remain open regarding its
interaction with NOD1 and NOD2, its precise role in MAPK
signalling and autophagy, the purpose of its kinase domain
and the role of its many post-translational modifications.
The domain architecture of RIP2 comprises an N-terminal
kinase domain, a central linker region and a C-terminal CARD
(figure 1). Structural information is currently available for its
kinase domain (PDB ID: 4C8B), which like RIP1 and RIP3
shows a typical kinase fold. The C-terminal CARD of RIP2 is
expected to form a six-helix bundle in accordance with the restof the death domain superfamily, whereas the central region is
thought to be broadly unstructured and highly flexible.
Overexpression of the tandemNOD2 CARDs is sufficient to
give a constitutive NF-kB response, but this does not happen
with either NOD2 CARD individually [1]. In line with this,
neither NOD2 CARD alone is able to bind RIP2 [1,37] and
specific point mutation within either of the NOD2 CARDs
abrogates RIP2 binding and prevents NF-kB signalling [4].
Accordingly, the shortest section of NOD2 reported to bind
to RIP2 is NOD2-S [66], which contains CARDa and the first
three helices of CARDb. Interestingly, despite being able to
bind RIP2, overexpression of NOD2-S does not activate NF-kB.
Taken together, these observations suggest that the engage-
ment of RIP2 by NODs is not sufficient for NF-kB activation
and would be consistent with recent observations of NOD1
and RIP2 [67]. Indeed, complete activation of RIP2-mediated
Table 2. RIP2 phosphorylation events.
residue reference
S168 Oppermann et al. [75]
S176 Dorsch et al. [76]
S363 Oppermann et al. [75] and Daub et al. [77]
Y381 Zhao et al. [78] and Tigno-Aranjuez et al. [79]
S393 Oppermann et al. [75]
Y474 Tigno-Aranjuez et al. [79]
Y520 Tigno-Aranjuez et al. [79]
S527 Oppermann et al. [75] and Daub et al. [77]
S529 Olsen et al. [80]
S531 Dephoure et al. [81]
S539 Oppermann et al. [75] and Daub et al. [77]
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6NOD2 signalling may require: the complex to assemble with a
specific conformation; post-translational modification; simul-
taneous interaction between the NOD2 CARDs themselves
or the binding of another essential protein. While the NOD1
and NOD2 CARDs have both been shown to self-associate
[37,67–69], it is not yet clear whether these interactions are
physiologically relevant. In addition, as discussed in this
review, various other proteins have been shown to interact
with NOD2 and to be crucial for successful activation of NF-kB.
The residues which mediate NOD1, NOD2 and RIP2 com-
plex formation are controversial and are complicated firstly by
the possibility that multiple interfaces may be involved in
CARD : CARD interactions and secondly by the potential struc-
tural roles of charged, surface residues in CARDs. A model for
the CARD : CARD interaction between NOD1 and RIP2 was
proposed by Manon et al. [70] in 2007 following their solution
of the NOD1 CARD structure by NMR (PDB ID: 2B1W). This
structure, combined with a homology model of RIP2 based on
the caspase-9 CARD, proposed two opposing charged surfaces,
one acidic on NOD1 and one basic on RIP2, which interact to
form a heterodimer. However, this original NMRmodel differs
significantly from subsequent crystallographic and NMR
NOD1 CARD structures [69,71,72].
Site-directed mutagenesis resulted in a model postulating
that three core acidic residues—E53, D54 and E56—formed
the core acidic patch on NOD1, whereas R444, R483 and R488
formed the RIP2 basic patch. Charge reversal mutants of any
one of these residues were able to disrupt the binding of
NOD1 to RIP2 almost completely, although the mutation
E56A has no impact onNOD1 signalling [60]. A charge reversal
mutation of R69 in NOD1 was also able to disrupt the NOD1 :
RIP2 interaction, though thiswas suggested to bedue to a desta-
bilization of the CARD fold [70]. More recently, it has been
shown that the interaction between NOD1 and RIP2 may
involve both a type I interface consisting of residues centred
around R38, R69 and R86 on NOD1 and D461 and Y474 on
RIP2; as well as a type III interface centred upon E53 and E56
onNOD1 and R483 on RIP2 [67]. This study also demonstrated
that the importance of D54 inNOD1 signalling and the engage-
ment of RIP2 resulted from its key role in stabilizing the NOD1
CARD structure through formation of an intramolecular salt
bridge with K78.
The core acidic trio identified in NOD1 is conserved in
NOD2 (E69, D70 and E72). However, there is contrasting evi-
dence regarding their role in RIP2 binding. Wagner et al. [37]
showed that E69K and D70K mutants disrupt RIP2 binding
in a yeast two-hybrid study, whereas Fridh et al. [68] gener-
ated the E69K and E72K mutants in E. coli constructs and
found that they are not necessary for RIP2 binding, instead
proposing that a basic patch on NOD2 CARDa interacts
with an acidic patch on the RIP2 CARD. These differences
may result from the utilization of different CARD : CARD
interfaces and the preference of different CARD : CARD com-
plexes under certain experimental conditions. However, it is
possible that the loss of interaction results from introduction
of a secondary mutation that destabilizes the protein fold,
rather thandisruptingan interaction surface.Certainly, different
groups have reported varying levels of difficulty in expressing
certain NOD1 and NOD2 mutants in E. coli, suggesting that
certain charged residues may contribute to the stability of the
CARD fold under specific conditions. For example, Manon
et al. [70] reported that the NOD1 R69E mutant is unstable;
Fridh et al. [68] showed that the NOD2 D58A, D70A, L145P,E166K and R182A mutants gave especially low expression;
and Ver Heul et al. [11] reported that E53K, D54K and E56K
mutants could not be expressed in E. coli, although Mayle
et al. [67] successfully produced both E53K and E56K.
These reports indicate that the mutation of numerous resi-
dues in the CARDs may be important for correct folding and
that such residues may exist outside the hydrophobic core.
Studies using mammalian cells may be especially prone to mis-
interpreting the roles of surface residues by not taking into
account slight or severe disruptions in the protein fold. For
example, early work on NOL3 and Bcl-10 CARD function
mutated different residues within their hydrophobic cores
(L31F and L41Q, respectively) to use as negative controls
[73,74]. These proteins still gave normal expression in HEK293
cells but had lost function, indicating that even severe, internal
mutations can be tolerated without preventing protein over-
expression. As such, the structural importance of surface
residues should be strongly considered in mutational studies
of CARDs. Future mutational work and structural evidence
will be required to clarify the stoichiometry and mode of
interaction between NOD2 and RIP2.6. The importance of post-translational
modification of RIP2 in NOD2 signalling
Functional analysis of RIP2 and broad studies of the protein
kinome have revealed that RIP2 is highly phosphorylated
(table 2). Phosphorylation of RIP2 tends to occur on exposed,
flexible regions. The two phosphoserine residues in the RIP2
kinase domain, S168 and S176, fall into an unsolved region in
the RIP2 crystal structure and the homologous residues in the
RIP1 and RIP3 crystal structures are also absent. Two phos-
phoserines detected by large-scale kinome analysis, S363
and S393, are found in the interdomain region of RIP2 along-
side Y381. Meanwhile, Y520, which borders the predicted
end of the CARD, is between two proline residues, and the
flexible C-terminal region of RIP2 contains four identified
phosphorylation sites—S527, S529, S531 and S539.
One phosphorylation event which is an exception to this
trend occurs at Y474, which falls in helix 3 of the RIP2 CARD
and corresponds to one of the key residues used by Apaf-1 to
form a type I interaction with procaspase-9. Mutation of this
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Figure 3. Signal transduction downstream of RIP2. (a) MEKK4 and RIP2 form a complex preventing RIP2 ubiquitination. (b) In the presence of MDP, the MEKK4 :
RIP2 complex dissociates and a NOD2 : RIP2 complex is able to form. (c) RIP2 is then ubiquitinated, leading to the recruitment of TAK1. (d ) The IKK complex is
recruited to RIP2 and IKKg is ubiquitinated by TAK1. (e) IKKg is then degraded by the proteasome, relieving inhibition of IKKa/b. ( f ) IKKa/b phosphorylates
IkBa which subsequently releases p65 (g), which then enters the nucleus to enhance transcription of inflammatory cytokines.
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7tyrosine in RIP2 reduces its ability to bind either NOD1 or
NOD2 [67,79]. It is conceivable that phosphorylation here may
be used to provide a negative charge for engaging an opposing,
basic surface. Intriguingly, the corresponding tyrosine residue is
phosphorylated in apoptosis-associated speck-like protein con-
taining aCARD (ASC), and this phosphorylation is described as
a switch that controls ASC speck formation [82]. It follows that
phosphorylation of RIP2 on Y474 could play a similar role in
directing the assembly of a CARD complex downstream of
NOD1 and NOD2. Various other CARDs have a tyrosine in
this position, and phosphorylation may play a broad role in
controlling type I CARD : CARD interactions.
At least five E3 ligases have been implicated recently in the
ubiquitination of RIP2: ITCH [83], cIAP1 [84], cIAP2 [84], XIAP
[85,86] and Pellino3 [87]. The ubiquitination events mediated
by the cIAPs, XIAP and Pellino3 are reported to increase signal-
ling to theNF-kB and JNK pathways, whereas ubiquitination by
ITCH reduces signalling to NF-kB in favour of JNK andMAPK
phosphorylation. A concurrent study of XIAP and Pellino3 con-
cluded that the twoE3 ligases act throughdifferentmechanisms,
because XIAP acted by recruiting Sharpin and Pellino3 did not
[87]. K209 has been identified as an important ubiquitination
site onRIP2 [88], but theE3 ligase responsible for this ubiquitina-
tion has not been determined, though ITCH and Pellino3 have
been ruled out [87]. The K209 residue is conserved in RIP1 and
RIP4 and may play a similar role in these proteins.7. Signal transduction downstream of RIP2
While NOD1 and NOD2 are autoinhibited until ligand acti-
vation, it has been suggested that RIP2 activity is kept in
check through an interaction with MEKK4. In this sequestra-
tion model (figure 3) [89], a MEKK4 : RIP2 complex exists
under basal conditions in the absence or presence of NOD2.
When MDP is introduced into this system, the MEKK4 : RIP2
complex dissociates and a NOD2 : RIP2 complex forms. Until
NOD2 is introduced, MEKK4 : RIP2 is stable in the presence
of MDP, suggesting that activated NOD2 competes for RIP2.This basal inhibition of the NOD2 : RIP2 complex formation
translates to an inhibition of NOD2–NF-kB signalling while
still allowing the activation of JNK by RIP2.
Following the release of RIP2 from the MEKK4 complex
and its binding to NOD2, it is ubiquitinated, leading to the
recruitment of TAK1 to its kinase domain. Simultaneous bind-
ing of the IKK complex to the RIP2 intermediate domain results
in ubiquitination of IKKg (NEMO) by TAK1 and its degra-
dation, which allows the IKKa and IKKb subunits to
phosphorylate IkBa. Phosphorylated IkBa is degraded, releas-
ing p65 and allowing its transport into the nucleus, where it
affects transcription (figure 3) [88,90].8. NOD2 and autophagy
Evolving froma stress response inunicellular organisms, autop-
hagy is a bulk degradation systemwhich economizes resources
under harsh conditions. While beyond the scope of this review,
this process is covered extensively elsewhere [91,92]. In multi-
cellular organisms, it is becoming evident that autophagy has
developed into a systemcapable of elicitinganti-microbial prop-
erties and is beginning to be connected to the influence of
multiple pattern recognition receptors. Interactions between
pattern recognition receptors and the autophagy machinery,
such as NOD1 and NOD2 with ATG16L1 [7], RIG-I with the
ATG5–ATG12 conjugate [93] and the NLRs NLRC4, NLRP3,
NLRP4, NLRP10 and NOD2 with Beclin-1 [14], establish a
firm linkbetweenpathogendetection andpathogen elimination.
The role of NOD1 and NOD2 in autophagy is a recent
discovery and to date is still in the early stages of investigation.
Multiple groups have shown NOD1- or NOD2-dependent
activation of autophagy when cells are stimulated with their
respective ligands [7,94]. However, the precise role that
NOD1 and NOD2 play in activating autophagy is currently
an area of controversy that may well show cell-dependent
phenotypic effects as outlined below.
Anoriginal studybyTravassos et al. [7] suggestedautophagy
was activated independently of RIP2 and NF-kB signalling,
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8instead showing an interaction between ATG16L1 and the
NODs. ATG16L1 is an essential component of the autophagic
machinery, forming a complex with ATG5–ATG12 conjugates
which function to dictate the site of LC3 lipidation in pre-
autophagic structures [95,96]. HeLa cells transfected with
ATG16L1 andNODswere infectedwith Shigella flexneri and dis-
played colocalization of the proteins at bacterial entry sites. This
membrane colocalization was abrogated when NOD2 was
replaced by the inactive, cytosolic frameshift SNP, fs1007insC,
which retained ATG16L1 in the cytosol. Therefore, this model
suggests that ATG16L1 is recruited to bacterial entry sites by
NOD2,pinpointing the localizationof the autophagicmachinery
[7]. A link between NOD2 and ATG16L1 as presented in this
model is of great fundamental importance, because SNPs in
both proteins are implicated in Crohn’s disease and hamper
autophagy induction [5,7,12].
To further support this theory, an interactionbetweenNOD1
or NOD2 with ATG16L1 has been shown using recombinant
protein pulldowns, implicating the CARDs of the NODs and
the WD40 repeats of ATG16L1 as the interacting domains [11].
A short stretch of peptides inNOD2CARDa has been suggested
to mediate this interaction. This is a binding motif which is also
present in other ATG16L1 binding proteins such as TMEM59
and TLR2 [12]. However, this motif is absent from NOD1
and indeed no interaction between NOD1 and ATG16L1 was
reported, leading to a discrepancy with the work of Travassos
et al. [7]. Comparative structural analysis suggests that the crucial
residues identified for this motif in NOD2 form part of the con-
served hydrophobic core, and so further analysis is necessary to
definitively show its involvement in binding.
More recently, increasing evidence has been gathered to
suggest an alternative mechanism of autophagy activation
which requires RIP2 [94,97–99]. Homer et al. [98] have demon-
strated the crucial nature of RIP2 kinase activity in relation
to autophagy. Treatment of HCT116 endothelial cells with
erlotinib, a RIP2 tyrosine kinase inhibitor, impeded LC3-II
accumulation on autophagic membranes. While all studies so
far have demonstrated the dispensable nature of NF-kB signal-
ling to autophagy [7,89,100], Homer et al. have shown that the
MAPK p38 is required for bacterial clearance. A RIP2 binding
partner,MEKK4, helps todictatewhetherNOD2signals through
NF-kBorMAPKpathways [89]. BecauseMEKK4 is also essential
for autophagy activation [98], this indicates that NOD2 activates
autophagy through a RIP2 pathway dependent upon MEKK4
activation of p38. This pathway is negatively regulated by
PP2A, which acts on an unknown target downstream of p38.
Upon stimulation byMDP, PP2A itself becomes phosphorylated
and downregulated in a process dependent upon RIP2 kinase
activity [98]. Whereas this report indicated that other MAPKs
such as JNK and ERK1 were not involved in an autophagic
response, Anand et al. [97] observed a marked reduction in
autophagic clearance of Listeria monocytogenes in dendritic cells
defective in ERK1. The differences seen in autophagic response
and MAPK involvement may in part be due to the different
cell types used in these studies [7,94,97–99,101], but further
work is needed for clarification.9. The importance of membrane
localization
NLRs are classically defined as cytosolic detectors in the
immune response. However, NOD1 and NOD2 partiallylocalize to the plasma and endosomal membrane of cells in
which they are endogenously expressed, a characteristic
which is replicated in cells where NODs have been overex-
pressed [45,100–102]. The exact mechanistic reason for this
redistribution of NODs towards the membrane remains
unclear but proposals include positioning of NODs to sites of
ligand entry [45], activation of autophagy at bacterial entry
sites [7] and regulation of NODs by binding partners
positioned at the membrane [25,26].
Recruitment of NOD2 to the membrane is dependent
upon Rac1, a Rho family GTPase. Rac1 and NOD2 co-
immunoprecipitate and co-localize at membrane ruffles, but
if Rac1 is knocked down then NOD2 membrane localization
is abrogated [13,40,103,104]. Classically, Rac1’s function has
been defined as modulation of the actin cytoskeleton, leading
to cell movement and membrane protrusions [105]. However,
it has also been implicated in cell proliferation, cell adhesion,
phagocytosis, interleukin production, superoxide production
and transcriptional regulation [106]. Salmonella infection of
intestinal epithelium cells is mediated by its manipulation
of host cell machinery, including Rac1, reorganizing the
actin cytoskeleton and allowing bacterial penetration of the
cell [107]. Therefore, a link between NOD2 and Rac1 connects
it to bacterial entry sites. It is unclear how Rac1 affects NOD2
membrane localization, but, because disruption of the actin
cytoskeleton also reduces the amount of NOD2 at the
membrane, it is possibly in an actin-dependent manner
[13,40,103,104]. Interestingly, NOD2 has also been implicated
in an interaction with CD147, a transmembrane glycoprotein
found to increase the invasiveness of L. monocytogenes [21].
Again, because invasion of this bacterium into cells will require
reorganization of the actin cytoskeleton, the link between
NOD2 and CD147 therefore serves to reinforce the connection
between bacterial invasion, the cytoskeleton and NOD2.
NOD2 binds to the peripheral membrane protein FERM
and PDZ-domain-containing 2 (FRMPD2), anchoring itself
to the membrane [26]. FRMPD2 is formed of an N-terminal
KIND domain, a central membrane-binding FERM domain
and three PDZ domains at the C-terminus functioning to
steer the protein to the membrane [108]. NOD2 and
FRMPD2 co-immunoprecipitate and co-localize together at
the membrane, an interaction which is mediated by the
LRR domain of NOD2 and the FERM and PDZ 2 domains
of FRMPD2. Knockdown of FRMPD2 reduces NOD2 pres-
ence at the membrane and reduces NOD2-induced NF-kB
activity [26]. Because both FRMPD2 and Rac1 have been
implicated in membrane recruitment of NOD2, it is unclear
why FRMPD2 should lead to an enhancement of activity
whereas Rac1 has a negative impact [13,40].
Once at the membrane, NOD2 interacts with a myriad of
additional binding partners. One possible reason for the
negative impact of Rac1 onNOD2 signalling [13] is the juxtaposi-
tion of NOD2 with negative regulators such as Erbin. This is a
transmembrane protein which both co-localizes with NOD2 at
bacterial entry sites and co-immunoprecipitates with it [24,25].
The pulldown of Erbin with NOD2 is enhanced during
infection; however, NOD2 is not dependent on Erbin for
membrane localization. Erbin has a negative impact on NOD2-
mediated NF-kB activity and may explain why disruption of
NOD2membrane recruitmentby inhibitingRac1 led to increased
NOD signalling [24,25]. In addition to Erbin, AAMP, CD147 and
RIG-I all reportedlybind toNOD2and elicit a negative impact on
NF-kB signalling.
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effect on NOD1/2 signalling. As well as FRMPD2, DUOX2
is also reported to enhance NF-kB signalling [23,26]. In
addition, the interaction of NOD2 and DUOX2 is reported
to be responsible for the NOD2-dependent reactive oxygen
species (ROS) production seen in Caco-2 cells following
MDP treatment. As well as enhancing NF-kB activity, this
ROS production was found to be important for protection
from L. monocytogenes [23].
NOD2 has been implicated in recruiting binding partners to
the membrane, forming active signalling complexes. A pool of
RIP2 is recruited to the membrane in a NOD2-dependent
fashion [43] and, similarly, ATG16L1 may also be recruited to
bacterial entry sites to induce autophagy [7]. So, while mem-
brane recruitment may be important for fine-tuning of NOD2
activity, it is also crucial for directing bacterial killing.017810. Conclusion
It is certain that proteins will continue to be identified that
influence NOD2 signalling, either through direct interaction
with the receptor, via a more general interaction with the sig-
nalling complex, or in more abstract manners. As this review
has highlighted, while some proteins are unique in their influ-
ence upon the NOD2 signalling pathway, there are others
which also influence NOD1 signalling. Without doubt, newly
identified proteinswill fall into both categories. Understandingwhat these cellular proteins are doing and indeedwhy they are
doing it is of paramount importance if we are to be able to
firstly understand NOD2 function, and second, specifically
modulate the NOD2 signalling pathway for therapeutic pur-
poses. This is particularly important if we are to differentiate
between the modulation of NOD1 and NOD2 signalling.
Indeed, we may find that it is through gaining an understand-
ing of the role of proteins that influence either NOD2 or NOD1
signalling that we really begin to understand the different
mechanisms of signalling activation and regulation between
these two closely related proteins. If we ignore the role and
function of these associated proteins in favour of focusing
solely on the perceived key players of NOD2 and RIP2, we
may miss opportunities for subtle, or specific, modulation
and run the risk of inadvertently affecting a wide range of cel-
lular processes.We also need to resolve the precise role of these
proteins in relation to particular cell types, under certain
conditions of stimulation, and in different species before we
can be confident that we really understand the cellular and
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